<https://rdf.molmedb.upol.cz/reference/ref2714> <http://purl.org/ontology/bibo/doi> "10.1021/acs.jmedchem.7b01751"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM473392>,
		<https://rdf.molmedb.upol.cz/interaction/membrane23>,
		<https://identifiers.org/molmedb/MM473391>;
	<http://purl.org/ontology/bibo/pmid> "29502405"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/bibliographicCitation> "Roberts RS, Sevilla S, Ferrer M, Taltavull J, Hernández B, Segarra V, Gràcia J, Lehner MD, Gavaldà A, Andrés M, Cabedo J, Vilella D, Eichhorn P, Calama E, Carcasona C, Miralpeix M.: 4-Amino-7,8-dihydro-1,6-naphthyridin-5(6 H)-ones as Inhaled Phosphodiesterase Type 4 (PDE4) Inhibitors: Structural Biology and Structure-Activity Relationships. J Med Chem, Volume 61 (6), 2018"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method30>,
		<https://rdf.molmedb.upol.cz/interaction/membrane18>,
		<https://identifiers.org/molmedb/MM473393> .
<https://rdf.molmedb.upol.cz/interaction/int981239> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2714> .
<https://rdf.molmedb.upol.cz/interaction/int981478> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2714> .
<https://rdf.molmedb.upol.cz/interaction/int981326> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2714> .
<https://rdf.molmedb.upol.cz/interaction/int1007123> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2714> .
<https://rdf.molmedb.upol.cz/interaction/int1007124> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2714> .